ARTICLE | Management Tracks
Baxter’s Accogli named CEO of Chiesi
Plus: J&J CMO Waldstreicher retiring, and updates from the Broad Institute, Ring, Hansa, Vaccitech and Beyond Air
January 31, 2023 1:20 AM UTC
Chiesi Farmaceutici S.p.A. named Giuseppe Accogli as new group CEO, effective April 3. Accogli is a 13- year veteran of Baxter International Inc. (NYSE:BAX), where he most recently was EVP and COO. Before Baxter, he held leadership roles at Medtronic plc (NYSE:MDT).
Joanne Waldstreicher announced last week that she will retire as CMO of Johnson & Johnson (NYSE:JNJ) in April. Waldstreicher, who was named CMO in 2012, has held several roles of increasing responsibilities at the company for 20 years...